Steven Cohen Ocular Therapeutix, Inc Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,904,214 shares of OCUL stock, worth $22 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,904,214
Previous 1,942,362
1.96%
Holding current value
$22 Million
Previous $14.2 Million
24.12%
% of portfolio
0.04%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding OCUL
# of Institutions
203Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$165 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$160 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$147 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$133 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$96.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $888M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...